Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.36	66.66	22.47	46.35	64.07	126.26
Short-Term Investments	117.64	171.3	147.56	92.01	22.68	26.01
Cash & Short-Term Investments	139.01	237.96	170.03	138.36	86.74	152.28
Cash Growth	-55.15%	39.95%	22.89%	59.50%	-43.04%	-43.95%
Receivables	2.18	3.47	1.01	0.03	0.01	0.4
Inventory	0.17	0.23	0.38	-	-	-
Prepaid Expenses	3.73	4.53	5.13	2.48	2.16	5.05
Total Current Assets	145.08	246.19	176.55	140.87	88.92	157.72
Property, Plant & Equipment	6.59	7.32	7.51	8.48	3.45	1.53
Goodwill	44.54	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	29.37	0.37	0.83	0.41	-	-
Total Assets	225.58	298.42	229.43	194.3	136.91	203.79
Accounts Payable	5.9	14.8	14.39	10.4	9.15	5.47
Accrued Expenses	10.57	29.27	15.87	11.49	11.88	29.14
Current Portion of Long-Term Debt	-	-	-	-	-	11.65
Current Portion of Leases	0.91	1.18	1.29	1.29	1.09	0.55
Current Unearned Revenue	17.46	-	-	-	-	-
Total Current Liabilities	34.84	45.25	31.55	23.17	22.12	46.81
Long-Term Debt	56.11	100.3	99.51	48.58	-	-
Long-Term Leases	4.4	4.6	5.27	5.42	1.19	0.61
Other Long-Term Liabilities	0.8	2.32	-	-	-	-
Total Liabilities	96.14	152.47	136.32	77.18	23.31	47.42
Common Stock	0.37	0.36	0.25	0.19	0.15	0.14
Additional Paid-In Capital	2,124	2,117	1,863	1,709	1,609	1,561
Retained Earnings	-1,989	-1,967	-1,767	-1,590	-1,488	-1,400
Treasury Stock	-5.19	-4.62	-2.89	-2.06	-7.52	-4.84
Comprehensive Income & Other	-0.01	0.12	0.03	-0.43	-0.01	-0.01
Shareholders' Equity	129.44	145.95	93.11	117.12	113.6	156.37
Total Liabilities & Equity	225.58	298.42	229.43	194.3	136.91	203.79
Total Debt	61.42	106.07	106.06	55.29	2.28	12.81
Net Cash (Debt)	77.59	131.88	63.96	83.06	84.46	139.47
Net Cash Growth	-62.02%	106.19%	-23.00%	-1.66%	-39.44%	461.88%
Net Cash Per Share	0.21	0.41	0.29	0.50	0.58	1.26
Filing Date Shares Outstanding	363.4	361.49	246.24	188.73	149.59	143.56
Total Common Shares Outstanding	363.4	361.49	244.92	188.73	148.92	141.5
Working Capital	110.25	200.95	145	117.69	66.8	110.91
Book Value Per Share	0.36	0.40	0.38	0.62	0.76	1.11
Tangible Book Value	84.9	101.41	48.57	72.58	69.05	111.83
Tangible Book Value Per Share	0.23	0.28	0.20	0.38	0.46	0.79
Machinery	2.39	2.39	4.35	4	4.72	5.69
Leasehold Improvements	2.18	2.18	2.18	2.05	1.31	0.42

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q